Patheon Inc. Announces Its Performance Guarantee



    RESEARCH TRIANGLE PARK, NC, June 9 /CNW/ - Patheon Inc. (TSX: PTI), a
global provider of drug development and manufacturing services to the
international pharmaceutical industry, announced today its launch of a new
performance guarantee initiative designed to enhance its service to customers.
The Patheon Performance Guarantee will be added as a new feature in commercial
manufacturing contracts for customers with critical supply requirements.
    This Patheon Performance Guarantee builds on Patheon's improving delivery
performance and its legacy of quality. The company now regularly exceeds 95%
on time, in full delivery and recently delivered 97.5% of customer orders on
time across the entire network. Patheon will guarantee delivery performance
while building on its reputation for exceptional quality and reliable
regulatory compliance. Patheon also reported over 94% right first time batch
production performance in April, its highest ever.
    Wes Wheeler, President and Chief Executive Officer of Patheon Inc.
stated, "Our customers regularly tell us that service and quality are their
most important criteria when evaluating contract manufacturers. We have spent
the past 18 months focused on measuring all aspects of our business with
particular focus on delivery, efficiency and quality. We are now ready to
stand by our performance with delivery guarantees."

    ABOUT PATHEON INC.

    Patheon Inc. (TSX: PTI; www.patheon.com) is a leading global provider of
contract development and manufacturing services to the pharmaceutical
industry. Patheon prides itself in providing the highest quality products and
services to more than 300 pharmaceutical and biotechnology companies.
Patheon's services range from preclinical development through the commercial
manufacturing of a wide array of dosage forms including parenteral, solid,
semi-solid and liquids. Patheon's comprehensive range of fully integrated
Pharmaceutical Development Services includes pre-formulation, formulation,
analytical development, clinical manufacturing, scale-up and
commercialization. Patheon's ability to integrate development and
manufacturing services ensures that our customers' projects are delivered on
time and meet the high standards of quality that Patheon is known for.
Patheon's integrated development and manufacturing network of 10 facilities
and 7 development centers, across North America and Europe, strives to ensure
that customer products can be launched timely and confidently anywhere in the
world.

    Caution Concerning Forward-Looking Statements

    This news release may contain forward-looking statements which reflect
management's expectations regarding the Company's future growth of operations,
performance (both operational and financial) and business prospects and
opportunities. These statements are made in the context of the risks and
uncertainties that are outlined in the Company's public documents, which can
be accessed on our website at www.patheon.com or on SEDAR at www.sedar.com.

    %SEDAR: 00001700E




For further information:

For further information: Mr. Wes Wheeler, President & Chief Executive
Officer, Tel: (919) 226-3200, Email: wes.wheeler@patheon.com; Mr. Eric Evans,
Chief Financial Officer, Tel: (919) 226-3200, Email: eric.evans@patheon.com

Organization Profile

Patheon Inc

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890